CA2500757A1 - Methode de criblage pour un polypeptide antimicrobien - Google Patents
Methode de criblage pour un polypeptide antimicrobien Download PDFInfo
- Publication number
- CA2500757A1 CA2500757A1 CA002500757A CA2500757A CA2500757A1 CA 2500757 A1 CA2500757 A1 CA 2500757A1 CA 002500757 A CA002500757 A CA 002500757A CA 2500757 A CA2500757 A CA 2500757A CA 2500757 A1 CA2500757 A1 CA 2500757A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- antimicrobial
- indicator
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne une méthode de criblage d'un polynucléotide codant un peptide antimicrobien (AMP) pour son activité antimicrobienne. Le polynucléotique est introduit dans une cellule hôte sous la commande d'un promoteur inductible. Le fait de permettre à des cellules hôtes, sensibles à l'AMP, de croître en l'absence d'AMP avant l'ajout de l'inducteur fait que suffisamment de cellules hôtes sont présentes pour produire suffisamment d'AMP, au lieu d'éliminer ou d'inhiber précocement des cellules hôtes en les cultivant dès le départ en présence d'AMP. Après l'ajout de l'inducteur et l'expression de l'AMP dans la cellule hôte, la cellule hôte est cultivée en présence de cellules indicatrices. Les cellules hôtes pouvant réduire la prolifération de cellules indicatrices sont sélectionnées. Le polynucléotide codant un AMP est introduit seulement dans un seul type de cellules hôte, mais l'activité de l'AMP vers différentes cellules indicatrices peut être testée sans qu'il soit nécessaire d'avoir recours à l'introduction du polynucléotide dans plusieurs cellules hôtes.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201518 | 2002-10-09 | ||
DKPA200201518 | 2002-10-09 | ||
DKPA200201854 | 2002-12-02 | ||
DKPA200201854 | 2002-12-02 | ||
PCT/DK2003/000669 WO2004033715A1 (fr) | 2002-10-09 | 2003-10-08 | Methode de criblage pour un polypeptide antimicrobien |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2500757A1 true CA2500757A1 (fr) | 2004-04-22 |
Family
ID=32094935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002500757A Abandoned CA2500757A1 (fr) | 2002-10-09 | 2003-10-08 | Methode de criblage pour un polypeptide antimicrobien |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1551993A1 (fr) |
AU (1) | AU2003269851A1 (fr) |
CA (1) | CA2500757A1 (fr) |
WO (1) | WO2004033715A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7148404B2 (en) * | 2004-05-04 | 2006-12-12 | Novozymes A/S | Antimicrobial polypeptides |
WO2006050611A1 (fr) * | 2004-11-12 | 2006-05-18 | The University Of British Columbia | Peptides antimicrobiens |
CA2593872A1 (fr) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Sequences de commande reagissant a des amp et leurs utilisations |
CA2981705A1 (fr) * | 2015-03-23 | 2016-09-29 | Riptide Bioscience, Inc. | Peptides antimicrobiens et leurs methodes d'utilisations |
US10413584B1 (en) | 2018-08-29 | 2019-09-17 | Riptide Bioscience, Inc. | Peptides having immunomodulatory properties |
US10548944B1 (en) | 2018-10-19 | 2020-02-04 | Riptide Bioscience, Inc. | Antimicrobial peptides and methods of using the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1707497A (en) * | 1996-01-23 | 1997-08-20 | Rigel Pharmaceuticals, Inc. | Methods for screening for transdominant intracellular effector peptides and rna molecules |
EP1187913A1 (fr) * | 1999-05-31 | 2002-03-20 | Novozymes A/S | Procede de criblage peptidique |
WO2002006517A2 (fr) * | 2000-07-19 | 2002-01-24 | Kairos Scientific, Inc. | Methodes a haut rendement permettant de preparer et de cribler des composes qui affectent la viabilite cellulaire |
DK1448595T3 (da) * | 2001-11-20 | 2007-02-19 | Novozymes As | Antimikrobielle polypeptider |
-
2003
- 2003-10-08 AU AU2003269851A patent/AU2003269851A1/en not_active Abandoned
- 2003-10-08 WO PCT/DK2003/000669 patent/WO2004033715A1/fr not_active Application Discontinuation
- 2003-10-08 CA CA002500757A patent/CA2500757A1/fr not_active Abandoned
- 2003-10-08 EP EP03750395A patent/EP1551993A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2004033715A1 (fr) | 2004-04-22 |
EP1551993A1 (fr) | 2005-07-13 |
AU2003269851A1 (en) | 2004-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU650737B2 (en) | Viral products | |
Ekengren et al. | Drosophila cecropin as an antifungal agent | |
Kumaresan et al. | A novel antimicrobial peptide derived from fish goose type lysozyme disrupts the membrane of Salmonella enterica | |
Tandeau de Marsac et al. | Expression of the larvicidal gene of Bacillus sphaericus 1593M in the cyanobacterium Anacystis nidulans R2 | |
KR101983668B1 (ko) | 그람 음성 박테리아에 대한 강한 항균 활성을 갖는 벌거숭이두더지쥐 유래의 항균성 폴리펩티드 및 이를 포함하는 약학 조성물 | |
Donpudsa et al. | Type I and type II crustins from Penaeus monodon, genetic variation and antimicrobial activity of the most abundant crustinPm4 | |
JP2001504321A (ja) | 微生物菌株プールを用いるスクリーニング方法 | |
KR101800407B1 (ko) | 비단뱀으로부터 분리한 신규한 항균 펩타이드 및 이의 발굴 방법 | |
CN108026155B (zh) | 新抗微生物肽、它们的变体和用途 | |
CA2500757A1 (fr) | Methode de criblage pour un polypeptide antimicrobien | |
Yasuda et al. | Phage genes induce quorum sensing signal release through membrane vesicle formation | |
Sarmasik et al. | Bactericidal activity of cecropin B and cecropin P1 expressed in fish cells (CHSE-214): application in controlling fish bacterial pathogens | |
US20060134630A1 (en) | Method for screening for an antimicrobial polypeptide | |
AU5208400A (en) | Screening method for peptides | |
KR102247293B1 (ko) | 항균 활성을 가지는 바실러스 서브틸리스 bsc35 균주 및 이의용도 | |
Schmellik-Sandage et al. | Signal strains that can detect certain DNA replication and membrane mutants of Escherichia coli: isolation of a new ssb allele, ssb-3 | |
Zalewska et al. | Isolation of Bacteriocin-producing spp. Strains from Human Skin Wounds, Soft Tissue Infections and Bovine Mastitis | |
Sharma et al. | Characterization of antimicrobial substance with antibiofilm activity from Pediococcus acidilactici | |
WO2005078116A1 (fr) | Methode permettant d'isoler de peptides antibacteriens et peptides isoles | |
Bonhi et al. | A comparative profile of bactericidal action of a partially purified bacteriocin from lactic acid bacteria with antibiotics. | |
AU2005209649B2 (en) | Screening method for peptides | |
Wooldridge et al. | Sensitivity of Escherichia coli to cloacin DF13 involves the major outer membrane protein OmpF | |
Wadhawan et al. | E. faecalis acquires resistance to antimicrobials and insect immunity via common mechanisms | |
US11096985B2 (en) | Antimicrobial peptides, their variants and uses | |
Cohen | Identification of Effectors of the Toll Pathway in Drosophila Innate Immunity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |